Table 1. Baseline characteristics of patients who underwent VATS.
| Characteristics | LBV (n=40) | BPV (n=40) | P |
|---|---|---|---|
| Age (years), mean ± SD | 67±9.8 | 69±11.3 | 0.383 |
| Male, n (%) | 17 (42.5) | 19 (47.5) | 0.653 |
| BMI, mean ± SD | 28.4±5.8 | 25.6±4.9 | 0.019* |
| Comorbidities, n (%) | |||
| Diabetes | 10 (25.0) | 4 (10.0) | 0.078 |
| COPD | 4 (10.0) | 2 (5.0) | 0.675 |
| CKD | 5 (12.5) | 9 (22.5) | 0.239 |
| Cardiovascular disease | 8 (20.0) | 9 (22.5) | 0.785 |
| HTN | 21 (52.5) | 22 (55.0) | 0.823 |
| Overweight/obese | 27 (67.5) | 24 (60.0) | 0.485 |
*, P<0.05 LBV, liposomal bupivacaine; BPV, standard release bupivacaine with epinephrine; BMI, body mass index; COPD, chronic obstructive pulmonary disease; CKD, chronic kidney disease; HTN, hypertension; VATS, video-assisted thoracoscopic surgery.